Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 8Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1Classical hematology 1

Conditions

Thrombocytopenia 1Solid Tumor 1Multiple Myeloma 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Has results × romiplostim × Clear all
NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
2 enrolled 4 charts
Other solid neoplasm

Solid Tumor

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

NYU Langone Health

Phase 2 Terminated
5 enrolled 4 charts
Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡